Pond Technologies

lockPrivate Group

We design and operate scalable bioreactors that use our society’s most abundant product – industrial greenhouse gases – and our specialized growing systems to cultivate algae and other crops. Our systems effectively close the carbon loop and create wealth from waste.

people4 Members       (0)

Corporate Profile
Group Admins:
  • Thumb 8020 monitor 200200 2
Request Membership


Pond Technologies

lockPrivateGroup

We design and operate scalable bioreactors that use our society’s most abundant product – industrial greenhouse gases......

people4 Members       (0)

Thumb 8020 monitor 200200 2

8020 Admin

9 days ago

8020 Admin posted a press release Applied Products Signs Agreement to Sell Pond Naturals' Supplements Including its X10 Pet Supplements in the U.S. in POND TECHNOLOGIES

BEVERLY HILLS, CA / ACCESSWIRE / October 24, 2019 / Applied Products ("Applied" or the "Company"), a division of Applied BioSciences Corp. (OTCQB:APPB) and Pond Technologies Holdings Inc. ("Pond") (TSX.V:POND), announced today that Pond Naturals, Pond's wholly owned subsidiary, has entered a three-year license agreement with Applied Products to expand the distribution of its astaxanthin-based pet supplement to the U.S. As part of the agreement, Pond will sell its X10-branded pet products through Applied Products' established online sales channels.


Applied BioSciences is focused on the development of science-driven biopharmaceuticals and the production of high-quality health and wellness products that target the endocannabinoid system. Through its Applied Products division, the Company currently develops multiple brands offering high quality health and wellness CBD products that conform to the highest regulatory standards and markets through established channels in the US, including its premium pet brand, Herbal Pet.


Grant Smith, Pond Naturals' President, commented, "Since its launch in April 2019, X10 has seen great traction in Canada as one of the only pet health products in the anti-aging category. Applied Products shares our values and will make for a great partner as we enter the US market through the existing Herbal Pet e-commerce channels."


Herbal Pet consists of a line of pet supplements that uses hemp-derived CBD to address conditions such as pain, inflammation, anxiety, or digestion. Applied Products intends to sell the Pond Naturals X10 product line alongside Herbal Pet products through its existing e-commerce channels. The Pond X10 product line contains a powerful antioxidant, astaxanthin, extracted from algae at Pond Natural's Agassiz, British Columbia facility. Astaxanthin is a naturally occurring fat-soluble super carotenoid found in certain microalgae with a unique range of health benefits.


"We are excited to introduce X10 to our loyal customer base as a synergistic product to our Herbal Pet CBD product line," Chris Bridges, Board Member of Applied Products, stated. "Adding X10 to our product portfolio allows us to specifically target senior pets whose owners may witness a noticeable improvement in mobility, energy, and attitude in their beloved companion animals."


The X10 product is designed to benefit ten aspects of a pet's health by reducing free radical damage which may promote recovery and slow down the natural effects of aging on the body. Visit www.X10Pet.com for more information on the pet product.


About Pond Technologies


Located in Markham, Ontario, Pond is a technology company that provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond's proprietary growth platform, including patented advanced photonics, optimizes key growth inputs in order to provide a controlled environment that maximizes the growth of algae and other organisms.


About Applied BioSciences Corp.


Applied BioSciences is a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics/ biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic areas. We also deliver high-quality consumer and OTC THC-free CBD products that promote overall health and wellbeing as well as state-of-the-art testing and analytics capabilities to our customers. For more information, visit the Company's website.


Safe Harbor Statement


Except for historical information contained herein, statements in this release may be forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to Applied Biosciences Corp. (the "Company") or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in the Company's filings with the Securities and Exchange Commission. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as (i) the development and protection of our brands and other intellectual property, (ii) the need to raise capital to meet business requirements, (iii) significant fluctuations in marketing expenses, (iv) the ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of our products and services, (v) the Company's ability to conduct the business if there are changes in laws, regulations, or government policies related to cannabis, (vi) management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and (vii) other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


Investor and Media Contact:
IR@appliedbiocorp.com
(833) 475-8247


SOURCE: Applied BioSciences Corp.


View source version on accesswire.com:
https://www.accesswire.com/564002/Applied-Products-Signs-Agreement-to-Sell-Pond-Naturals-Supplements-Including-its-X10-Pet-Supplements-in-the-US

!
Thumb 8020 monitor 200200 2

8020 Admin

12 days ago

8020 Admin posted a press release Pond Technologies subsidiary, PaiGE Growth Technologies Inc., signs MOU with vertical farmer CubicFarm Systems Corp. in POND TECHNOLOGIES


CALGARY, Oct. 21, 2019 /CNW/ - Pond Technologies Holdings Inc. ("Pond"), (TSX.V: POND) is pleased to announce that on October 18, 2019 its subsidiary PaiGE Growth Technologies Inc. ("PaiGE") entered into a Memorandum of Understanding ("MOU") with CubicFarm Systems Corp. ("CubicFarms") to study the effectiveness of combining CubicFarms vertical farming systems with PaiGE technology. If successful, the partners expect to provide an improved, efficient, modular and readily deployable system to grow vegetables or terrestrial plants using the latest advances in precision agriculture and vertical farming. 


CubicFarms is commercializing industrial-scale vertical farming systems for multiple industries worldwide. The CubicFarms platform consists of a containerized, automated and environment-controlled system where trays of high-value crops like leafy vegetables and herbs follow a patented, undulating path that ensures ideal growing conditions.


Pond has developed a growth platform for algae and terrestrial plants using proprietary lighting, controls and artificial intelligence. Pond has granted PaiGE an exclusive license for the application and further advancement of this technology for terrestrial plants.


As part of the MOU, PaiGE and CubicFarms envisage a multi-phase study to test the improvements from retrofitting the CubicFarms system with PaiGE technology. Each phase shall compare plant growth and resource input in a PaiGE-equipped growth cube against a standard unit – first incorporating proprietary lighting, then sensors, and finally a precision nutrient and water dosing system. In each phase, PaiGE shall provide the engineering design, coordinate equipment manufacturing and installation, and run and assess trials. If the trials prove successful and CubicFarms decides to incorporate PaiGE technology into its growth cubes, CubicFarms agrees to pay PaiGE licensing fees for its technology. PaiGE shall retain intellectual property developed by it throughout the joint project.


Dave Dinesen, CubicFarm's CEO commented: "Our commercial-scale modular CubicFarm growing machines allow our partner farmers to increase local production of nutritious vegetables, herbs, and many other crops, helping to address both food security and the environmental footprint associated with transportation. We're excited to incorporate PaiGE precision technology with the goal of improving resource efficiency and crop yields."


Steve Martin, PaiGE CEO stated: "The partnership with CubicFarms allows us to demonstrate Pond's growth technology in the terrestrial environment, potentially opening the door to a whole new category of applications. CubicFarms is the ideal partner for us to evolve the PaiGE technology as their growth cubes provide a fully controlled environment – similar to Pond algae bioreactors. As a technology provider to CubicFarms, we are excited to support their mission of advancing sustainable precision agriculture and vertical farming."


Forward Looking Statements:


This press release contains forward-looking statements within the meaning of applicable securities laws, including statements regarding Pond and its subsidiaries and expected results from its subsidiary PaiGE growth environment management systems. Such forward-looking statements are based on certain key expectations and assumptions made by Pond. Although Pond believes that the expectations and assumptions on which these forward-looking statements are based are reasonable, readers should not place undue reliance on these statements and Pond can give no assurance that they will prove to be correct. Pond does not undertake any obligation to update this forward-looking information except as required by law. For more information visit https://www.pondtech.com/paige and review our most recent Managements Discussion & Analysis filed on sedar.com.


About CubicFarm Systems Corp.
CubicFarm® Systems Corp. ("CubicFarms") is an agtech company commercializing large scale, vertical farming solutions for multiple markets worldwide. Founded in 2015, the company's mission is to provide industries around the world with efficient growing systems capable of producing predictable crop yields. Using its unique, patented undulating growing system, CubicFarms solves the two main challenges within the indoor farming industry: high electricity and labour costs. Currently, CubicFarms cultivates living lettuce, living basil and microgreens at its own facility in Pitt Meadows, British Columbia and is partnering with other companies to establish facilities around the world. For more information, visit www.cubicfarms.com.


About Pond Technologies Inc. and PaiGE Growth Technologies Inc:
PaiGE Growth Technologies Inc. ("PaiGE") is an affiliate of Pond Technologies Inc. ("Pond") which has developed lighting, controls and growth platform technology ("Pond Technology") for the growth of algae and cyanobacteria in enclosed bio-reactors.  Pond has granted PaiGE an exclusive license for the application and further development of the Pond Technology for growing terrestrial plants. Pond provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond's proprietary growth platform enables industrial emitters to generate new revenue streams from the transformation of underutilized CO2 to valuable algae-based products, such as protein for animal feed and nutraceutical products like Chlorella, Spirulina, and Astaxanthin for human consumption. For more information visit https://www.pondtech.com/.


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved of the information contained herein.


SOURCE Pond Technologies Holdings Inc.


View original content: http://www.newswire.ca/en/releases/archive/October2019/21/c3687.html



Steve Martin, Chief Executive Officer, at s.martin@pondtech.com , 416-287-3835 ext. 201; Chris Cory at c.cory@pondtech.com , 416‐287‐3835 ext. 215

!
Thumb 8020 monitor 200200 2

8020 Admin

16 days ago

8020 Admin posted a press release Pond Naturals Signs Agreement to Sell its X10 Pet Supplement in the US alongside CBD-based Herbal Pet products in POND TECHNOLOGIES


CALGARY, Oct. 17, 2019 /CNW/ - Pond Technologies Holdings Inc. ("Pond") (TSX.V: POND) is pleased to announce that Pond Naturals, its wholly owned subsidiary, is expanding the distribution of its astaxanthin-based pet supplement to the US. Pond Naturals has entered a three-year license agreement with Applied BioSciences ("Applied Bio") https://appliedbiocorp.com/ to sell its X10-branded pet products through Applied Bio's online sales channels.


Nevada based Applied Bio develops and markets CBD-based therapeutics and biopharmaceuticals through established channels in the US, including its premium pet brand, Herbal Pet. Applied Bio intends to sell X10 products alongside Herbal Pet products through its existing e-commerce channels.


Herbal Pet has developed a line of pet supplements that uses hemp-derived CBD to address conditions such as pain, inflammation, anxiety, or digestion (www.HerbalPet.com). X10 is a great complementary product to Herbal Pet as it contains nature's most powerful antioxidant: astaxanthin ('asta-zan-thin'), extracted from algae at Pond Natural's Agassiz, British Columbia facility (www.X10Pet.com).


Like Herbal Pet, X10 targets the premium pet segment, using only natural and vegan ingredients.  


London, UK based research firm, Technavio, estimates that the global pet dietary supplements market will grow by US$624 Million through 2023, or at a 5% CAGR. It identifies the launch of high quality pet dietary supplements as a key driver of this growth.


Chris Bridges, Applied Bio President, stated,


"We are excited to introduce X10 to our loyal customer base as a great complementary product to Herbal Pet's CBD line. While CBD can act quickly in the body, astaxanthin provides long-term relief from chronic conditions, making for an intriguing one-two punch of natural health products. Adding X10 to our product portfolio allows us to specifically target senior pets whose owners may witness a noticeable improvement in mobility, energy, and attitude in their furry family members."


Grant Smith, Pond Naturals President, commented,


"Since its launch in April 2019, X10 has seen great traction in Canada as one of the only pet health products in the anti-aging category. Applied Bio shares our values and will make for a great partner as we enter the US market through the existing Herbal Pet e-commerce channels."


Studies support astaxanthin supplements (also marketed as "red algae" in the skincare industry) as beneficial for humans and animals alike. The X10 product is designed to benefit ten aspects of a pet's health by reducing free radical damage which may promote recovery and slow down the natural effects of aging on the body. Visit www.X10Pet.com for more information on the pet product and www.Regenurex.com for scientific studies and orders of the pet and human supplements in Canada.


About Pond Technologies


Located in Markham, Ontario, Pond is a technology company that provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond's proprietary growth platform, including patented advanced photonics, optimizes key growth inputs in order to provide a controlled environment that maximizes the growth of algae and other organisms.


About Applied BioSciences Corp.


Applied BioSciences is a vertically integrated company focused on the development of science-driven cannabinoid therapeutics / biopharmaceuticals and delivering high-quality CBD products as well as state-of-the-art testing and analytics capabilities to our customers. For more information, visit the Company's website.


Forward Looking Statements


This news release contains forward-looking statements within the meaning of applicable securities laws, including statements identified by words such as "focused", "plan", "aimed", "opportunity", "designed", "expected", or similar expressions and includes suggestions of future outcomes, including statements about: plans to pursue vertical integration for high-value algae products; the ability to capture margins through vertical integration; the ability to commercially leverage its facility; the introduction of technology to increase astaxanthin production; the benefit designs of X10 and the ability to capture higher margins from branded consumer products. Although Pond believes that the expectations represented by such forward-looking statements are reasonable, there can be no assurance that such expectations will provide to be correct. Readers are cautioned not to place undue reliance on forward-looking statements as actual results may differ materially from those expressed or implied. The factors or assumptions on which the forward-looking statements are based include: the ability to commercialize product at current facilities; the ability to secure appropriate funding or financing; stable or increasing demand for premium consumer products; and the ability to access and implement the technology necessary to achieve expected future results. See www.Regenurex.com and www.X10Pet.com for a summary of condition-specific scientific studies relating to astaxanthin extracted from microalgae.


Additional information about risks, assumptions, uncertainties and other factors that could influence Pond's business is provided in Pond's most recent Management's Discussion & Analysis, available on SEDAR at sedar.com and on Pond's website.


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved of the information contained herein.


SOURCE Pond Technologies Holdings Inc.


View original content: http://www.newswire.ca/en/releases/archive/October2019/17/c1603.html

Chris Cory, c.cory@pondtech.com, 416-287-3835 ext. 215; Grant Smith at g.smith@pondtech.com, 416‐287‐3835 ext. 215

!

Pond Technologies

lockPrivate Group

We design and operate scalable bioreactors that use our society’s most abundant product – industrial greenhouse gases – and our specialized growing systems to cultivate algae and other crops. Our systems effectively close the carbon loop and create wealth from waste.

people4 Members       (0)

Corporate Profile
Group Admins:
  • Thumb 8020 monitor 200200 2
Request Membership


Pond Technologies

lockPrivateGroup

We design and operate scalable bioreactors that use our society’s most abundant product – industrial greenhouse gases......

people4 Members       (0)

Thumb 8020 monitor 200200 2

8020 Admin

9 days ago

8020 Admin posted a press release Applied Products Signs Agreement to Sell Pond Naturals' Supplements Including its X10 Pet Supplements in the U.S. in POND TECHNOLOGIES

BEVERLY HILLS, CA / ACCESSWIRE / October 24, 2019 / Applied Products ("Applied" or the "Company"), a division of Applied BioSciences Corp. (OTCQB:APPB) and Pond Technologies Holdings Inc. ("Pond") (TSX.V:POND), announced today that Pond Naturals, Pond's wholly owned subsidiary, has entered a three-year license agreement with Applied Products to expand the distribution of its astaxanthin-based pet supplement to the U.S. As part of the agreement, Pond will sell its X10-branded pet products through Applied Products' established online sales channels.


Applied BioSciences is focused on the development of science-driven biopharmaceuticals and the production of high-quality health and wellness products that target the endocannabinoid system. Through its Applied Products division, the Company currently develops multiple brands offering high quality health and wellness CBD products that conform to the highest regulatory standards and markets through established channels in the US, including its premium pet brand, Herbal Pet.


Grant Smith, Pond Naturals' President, commented, "Since its launch in April 2019, X10 has seen great traction in Canada as one of the only pet health products in the anti-aging category. Applied Products shares our values and will make for a great partner as we enter the US market through the existing Herbal Pet e-commerce channels."


Herbal Pet consists of a line of pet supplements that uses hemp-derived CBD to address conditions such as pain, inflammation, anxiety, or digestion. Applied Products intends to sell the Pond Naturals X10 product line alongside Herbal Pet products through its existing e-commerce channels. The Pond X10 product line contains a powerful antioxidant, astaxanthin, extracted from algae at Pond Natural's Agassiz, British Columbia facility. Astaxanthin is a naturally occurring fat-soluble super carotenoid found in certain microalgae with a unique range of health benefits.


"We are excited to introduce X10 to our loyal customer base as a synergistic product to our Herbal Pet CBD product line," Chris Bridges, Board Member of Applied Products, stated. "Adding X10 to our product portfolio allows us to specifically target senior pets whose owners may witness a noticeable improvement in mobility, energy, and attitude in their beloved companion animals."


The X10 product is designed to benefit ten aspects of a pet's health by reducing free radical damage which may promote recovery and slow down the natural effects of aging on the body. Visit www.X10Pet.com for more information on the pet product.


About Pond Technologies


Located in Markham, Ontario, Pond is a technology company that provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond's proprietary growth platform, including patented advanced photonics, optimizes key growth inputs in order to provide a controlled environment that maximizes the growth of algae and other organisms.


About Applied BioSciences Corp.


Applied BioSciences is a vertically integrated company focused on the development and commercialization of novel, science-driven, synthetic cannabinoid therapeutics/ biopharmaceuticals that target the endocannabinoid system to treat a wide-range of diseases across multiple therapeutic areas. We also deliver high-quality consumer and OTC THC-free CBD products that promote overall health and wellbeing as well as state-of-the-art testing and analytics capabilities to our customers. For more information, visit the Company's website.


Safe Harbor Statement


Except for historical information contained herein, statements in this release may be forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to Applied Biosciences Corp. (the "Company") or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the Company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in the Company's filings with the Securities and Exchange Commission. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as (i) the development and protection of our brands and other intellectual property, (ii) the need to raise capital to meet business requirements, (iii) significant fluctuations in marketing expenses, (iv) the ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of our products and services, (v) the Company's ability to conduct the business if there are changes in laws, regulations, or government policies related to cannabis, (vi) management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and (vii) other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


Investor and Media Contact:
IR@appliedbiocorp.com
(833) 475-8247


SOURCE: Applied BioSciences Corp.


View source version on accesswire.com:
https://www.accesswire.com/564002/Applied-Products-Signs-Agreement-to-Sell-Pond-Naturals-Supplements-Including-its-X10-Pet-Supplements-in-the-US

!
Thumb 8020 monitor 200200 2

8020 Admin

12 days ago

8020 Admin posted a press release Pond Technologies subsidiary, PaiGE Growth Technologies Inc., signs MOU with vertical farmer CubicFarm Systems Corp. in POND TECHNOLOGIES


CALGARY, Oct. 21, 2019 /CNW/ - Pond Technologies Holdings Inc. ("Pond"), (TSX.V: POND) is pleased to announce that on October 18, 2019 its subsidiary PaiGE Growth Technologies Inc. ("PaiGE") entered into a Memorandum of Understanding ("MOU") with CubicFarm Systems Corp. ("CubicFarms") to study the effectiveness of combining CubicFarms vertical farming systems with PaiGE technology. If successful, the partners expect to provide an improved, efficient, modular and readily deployable system to grow vegetables or terrestrial plants using the latest advances in precision agriculture and vertical farming. 


CubicFarms is commercializing industrial-scale vertical farming systems for multiple industries worldwide. The CubicFarms platform consists of a containerized, automated and environment-controlled system where trays of high-value crops like leafy vegetables and herbs follow a patented, undulating path that ensures ideal growing conditions.


Pond has developed a growth platform for algae and terrestrial plants using proprietary lighting, controls and artificial intelligence. Pond has granted PaiGE an exclusive license for the application and further advancement of this technology for terrestrial plants.


As part of the MOU, PaiGE and CubicFarms envisage a multi-phase study to test the improvements from retrofitting the CubicFarms system with PaiGE technology. Each phase shall compare plant growth and resource input in a PaiGE-equipped growth cube against a standard unit – first incorporating proprietary lighting, then sensors, and finally a precision nutrient and water dosing system. In each phase, PaiGE shall provide the engineering design, coordinate equipment manufacturing and installation, and run and assess trials. If the trials prove successful and CubicFarms decides to incorporate PaiGE technology into its growth cubes, CubicFarms agrees to pay PaiGE licensing fees for its technology. PaiGE shall retain intellectual property developed by it throughout the joint project.


Dave Dinesen, CubicFarm's CEO commented: "Our commercial-scale modular CubicFarm growing machines allow our partner farmers to increase local production of nutritious vegetables, herbs, and many other crops, helping to address both food security and the environmental footprint associated with transportation. We're excited to incorporate PaiGE precision technology with the goal of improving resource efficiency and crop yields."


Steve Martin, PaiGE CEO stated: "The partnership with CubicFarms allows us to demonstrate Pond's growth technology in the terrestrial environment, potentially opening the door to a whole new category of applications. CubicFarms is the ideal partner for us to evolve the PaiGE technology as their growth cubes provide a fully controlled environment – similar to Pond algae bioreactors. As a technology provider to CubicFarms, we are excited to support their mission of advancing sustainable precision agriculture and vertical farming."


Forward Looking Statements:


This press release contains forward-looking statements within the meaning of applicable securities laws, including statements regarding Pond and its subsidiaries and expected results from its subsidiary PaiGE growth environment management systems. Such forward-looking statements are based on certain key expectations and assumptions made by Pond. Although Pond believes that the expectations and assumptions on which these forward-looking statements are based are reasonable, readers should not place undue reliance on these statements and Pond can give no assurance that they will prove to be correct. Pond does not undertake any obligation to update this forward-looking information except as required by law. For more information visit https://www.pondtech.com/paige and review our most recent Managements Discussion & Analysis filed on sedar.com.


About CubicFarm Systems Corp.
CubicFarm® Systems Corp. ("CubicFarms") is an agtech company commercializing large scale, vertical farming solutions for multiple markets worldwide. Founded in 2015, the company's mission is to provide industries around the world with efficient growing systems capable of producing predictable crop yields. Using its unique, patented undulating growing system, CubicFarms solves the two main challenges within the indoor farming industry: high electricity and labour costs. Currently, CubicFarms cultivates living lettuce, living basil and microgreens at its own facility in Pitt Meadows, British Columbia and is partnering with other companies to establish facilities around the world. For more information, visit www.cubicfarms.com.


About Pond Technologies Inc. and PaiGE Growth Technologies Inc:
PaiGE Growth Technologies Inc. ("PaiGE") is an affiliate of Pond Technologies Inc. ("Pond") which has developed lighting, controls and growth platform technology ("Pond Technology") for the growth of algae and cyanobacteria in enclosed bio-reactors.  Pond has granted PaiGE an exclusive license for the application and further development of the Pond Technology for growing terrestrial plants. Pond provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond's proprietary growth platform enables industrial emitters to generate new revenue streams from the transformation of underutilized CO2 to valuable algae-based products, such as protein for animal feed and nutraceutical products like Chlorella, Spirulina, and Astaxanthin for human consumption. For more information visit https://www.pondtech.com/.


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved of the information contained herein.


SOURCE Pond Technologies Holdings Inc.


View original content: http://www.newswire.ca/en/releases/archive/October2019/21/c3687.html



Steve Martin, Chief Executive Officer, at s.martin@pondtech.com , 416-287-3835 ext. 201; Chris Cory at c.cory@pondtech.com , 416‐287‐3835 ext. 215

!
Thumb 8020 monitor 200200 2

8020 Admin

16 days ago

8020 Admin posted a press release Pond Naturals Signs Agreement to Sell its X10 Pet Supplement in the US alongside CBD-based Herbal Pet products in POND TECHNOLOGIES


CALGARY, Oct. 17, 2019 /CNW/ - Pond Technologies Holdings Inc. ("Pond") (TSX.V: POND) is pleased to announce that Pond Naturals, its wholly owned subsidiary, is expanding the distribution of its astaxanthin-based pet supplement to the US. Pond Naturals has entered a three-year license agreement with Applied BioSciences ("Applied Bio") https://appliedbiocorp.com/ to sell its X10-branded pet products through Applied Bio's online sales channels.


Nevada based Applied Bio develops and markets CBD-based therapeutics and biopharmaceuticals through established channels in the US, including its premium pet brand, Herbal Pet. Applied Bio intends to sell X10 products alongside Herbal Pet products through its existing e-commerce channels.


Herbal Pet has developed a line of pet supplements that uses hemp-derived CBD to address conditions such as pain, inflammation, anxiety, or digestion (www.HerbalPet.com). X10 is a great complementary product to Herbal Pet as it contains nature's most powerful antioxidant: astaxanthin ('asta-zan-thin'), extracted from algae at Pond Natural's Agassiz, British Columbia facility (www.X10Pet.com).


Like Herbal Pet, X10 targets the premium pet segment, using only natural and vegan ingredients.  


London, UK based research firm, Technavio, estimates that the global pet dietary supplements market will grow by US$624 Million through 2023, or at a 5% CAGR. It identifies the launch of high quality pet dietary supplements as a key driver of this growth.


Chris Bridges, Applied Bio President, stated,


"We are excited to introduce X10 to our loyal customer base as a great complementary product to Herbal Pet's CBD line. While CBD can act quickly in the body, astaxanthin provides long-term relief from chronic conditions, making for an intriguing one-two punch of natural health products. Adding X10 to our product portfolio allows us to specifically target senior pets whose owners may witness a noticeable improvement in mobility, energy, and attitude in their furry family members."


Grant Smith, Pond Naturals President, commented,


"Since its launch in April 2019, X10 has seen great traction in Canada as one of the only pet health products in the anti-aging category. Applied Bio shares our values and will make for a great partner as we enter the US market through the existing Herbal Pet e-commerce channels."


Studies support astaxanthin supplements (also marketed as "red algae" in the skincare industry) as beneficial for humans and animals alike. The X10 product is designed to benefit ten aspects of a pet's health by reducing free radical damage which may promote recovery and slow down the natural effects of aging on the body. Visit www.X10Pet.com for more information on the pet product and www.Regenurex.com for scientific studies and orders of the pet and human supplements in Canada.


About Pond Technologies


Located in Markham, Ontario, Pond is a technology company that provides profitable solutions to the global health and wellness challenges of climate change and nutrition. Pond's proprietary growth platform, including patented advanced photonics, optimizes key growth inputs in order to provide a controlled environment that maximizes the growth of algae and other organisms.


About Applied BioSciences Corp.


Applied BioSciences is a vertically integrated company focused on the development of science-driven cannabinoid therapeutics / biopharmaceuticals and delivering high-quality CBD products as well as state-of-the-art testing and analytics capabilities to our customers. For more information, visit the Company's website.


Forward Looking Statements


This news release contains forward-looking statements within the meaning of applicable securities laws, including statements identified by words such as "focused", "plan", "aimed", "opportunity", "designed", "expected", or similar expressions and includes suggestions of future outcomes, including statements about: plans to pursue vertical integration for high-value algae products; the ability to capture margins through vertical integration; the ability to commercially leverage its facility; the introduction of technology to increase astaxanthin production; the benefit designs of X10 and the ability to capture higher margins from branded consumer products. Although Pond believes that the expectations represented by such forward-looking statements are reasonable, there can be no assurance that such expectations will provide to be correct. Readers are cautioned not to place undue reliance on forward-looking statements as actual results may differ materially from those expressed or implied. The factors or assumptions on which the forward-looking statements are based include: the ability to commercialize product at current facilities; the ability to secure appropriate funding or financing; stable or increasing demand for premium consumer products; and the ability to access and implement the technology necessary to achieve expected future results. See www.Regenurex.com and www.X10Pet.com for a summary of condition-specific scientific studies relating to astaxanthin extracted from microalgae.


Additional information about risks, assumptions, uncertainties and other factors that could influence Pond's business is provided in Pond's most recent Management's Discussion & Analysis, available on SEDAR at sedar.com and on Pond's website.


Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved of the information contained herein.


SOURCE Pond Technologies Holdings Inc.


View original content: http://www.newswire.ca/en/releases/archive/October2019/17/c1603.html

Chris Cory, c.cory@pondtech.com, 416-287-3835 ext. 215; Grant Smith at g.smith@pondtech.com, 416‐287‐3835 ext. 215

!